Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus

Fat Moon Suk, Min Hui Lin, Margaret Newman, Shann Pan, Sheng Hsuan Chen, Jean Dean Liu, Chiaho Shih

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Mutations of human hepatitis B virus (HBV) occur frequently within the capsid (core) protein in natural infections. The most frequent mutation of the core protein in HBV from Southeast Asia occurs at amino acid 97, changing an isoleucine (I) to a leucine (L). In our systematic study of virus-host interactions, we have examined the replication efficiency of a site-directed mutant, I97L, and its parental wild-type HBV in several different hepatoma cell lines. Interestingly, we found that this capsid variant replicated in human Huh7 hepatoma cells approximately 4.8-fold better than its parental wild-type HBV. A similar phenomenon was observed in another hepatoma cell line, J3. In addition, the level of encapsidated RNA pregenome in mutant I97L was about 5.7-fold higher than that of the wild-type HBV in Huh7 cells. Unlike Huh7 cells, no significant difference in viral DNA replication between the same I97L mutant and its parental wild-type HBV was observed in HepG2, a human hepatoblastoma cell line. This finding of a profound replication advantage for mutant I97L in Huh7 and J3 cells but not in HepG2 cells may have important implications for the emergence of this mutant in chronic HBV carriers. We speculate here that the mutation confers a host factor-independent growth advantage for the survival of HBV variants in gradually dedifferentiating hepatocytes and thus helps prolong viral persistence.

Original languageEnglish
Pages (from-to)12069-12077
Number of pages9
JournalJournal of Virology
Volume76
Issue number23
DOIs
Publication statusPublished - Dec 2002
Externally publishedYes

Fingerprint

capsid
Hepatitis B virus
Capsid
Phenotype
mutation
phenotype
Mutation
hepatoma
mutants
Hepatocellular Carcinoma
Cell Line
cells
cell lines
chronic hepatitis B
Hepatoblastoma
Southeastern Asia
human cell lines
Isoleucine
Viral DNA
Chronic Hepatitis B

ASJC Scopus subject areas

  • Immunology

Cite this

Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus. / Suk, Fat Moon; Lin, Min Hui; Newman, Margaret; Pan, Shann; Chen, Sheng Hsuan; Liu, Jean Dean; Shih, Chiaho.

In: Journal of Virology, Vol. 76, No. 23, 12.2002, p. 12069-12077.

Research output: Contribution to journalArticle

@article{63a56efb64234a9bb1795815ed9ba2ac,
title = "Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus",
abstract = "Mutations of human hepatitis B virus (HBV) occur frequently within the capsid (core) protein in natural infections. The most frequent mutation of the core protein in HBV from Southeast Asia occurs at amino acid 97, changing an isoleucine (I) to a leucine (L). In our systematic study of virus-host interactions, we have examined the replication efficiency of a site-directed mutant, I97L, and its parental wild-type HBV in several different hepatoma cell lines. Interestingly, we found that this capsid variant replicated in human Huh7 hepatoma cells approximately 4.8-fold better than its parental wild-type HBV. A similar phenomenon was observed in another hepatoma cell line, J3. In addition, the level of encapsidated RNA pregenome in mutant I97L was about 5.7-fold higher than that of the wild-type HBV in Huh7 cells. Unlike Huh7 cells, no significant difference in viral DNA replication between the same I97L mutant and its parental wild-type HBV was observed in HepG2, a human hepatoblastoma cell line. This finding of a profound replication advantage for mutant I97L in Huh7 and J3 cells but not in HepG2 cells may have important implications for the emergence of this mutant in chronic HBV carriers. We speculate here that the mutation confers a host factor-independent growth advantage for the survival of HBV variants in gradually dedifferentiating hepatocytes and thus helps prolong viral persistence.",
author = "Suk, {Fat Moon} and Lin, {Min Hui} and Margaret Newman and Shann Pan and Chen, {Sheng Hsuan} and Liu, {Jean Dean} and Chiaho Shih",
year = "2002",
month = "12",
doi = "10.1128/JVI.76.23.12069-12077.2002",
language = "English",
volume = "76",
pages = "12069--12077",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "23",

}

TY - JOUR

T1 - Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus

AU - Suk, Fat Moon

AU - Lin, Min Hui

AU - Newman, Margaret

AU - Pan, Shann

AU - Chen, Sheng Hsuan

AU - Liu, Jean Dean

AU - Shih, Chiaho

PY - 2002/12

Y1 - 2002/12

N2 - Mutations of human hepatitis B virus (HBV) occur frequently within the capsid (core) protein in natural infections. The most frequent mutation of the core protein in HBV from Southeast Asia occurs at amino acid 97, changing an isoleucine (I) to a leucine (L). In our systematic study of virus-host interactions, we have examined the replication efficiency of a site-directed mutant, I97L, and its parental wild-type HBV in several different hepatoma cell lines. Interestingly, we found that this capsid variant replicated in human Huh7 hepatoma cells approximately 4.8-fold better than its parental wild-type HBV. A similar phenomenon was observed in another hepatoma cell line, J3. In addition, the level of encapsidated RNA pregenome in mutant I97L was about 5.7-fold higher than that of the wild-type HBV in Huh7 cells. Unlike Huh7 cells, no significant difference in viral DNA replication between the same I97L mutant and its parental wild-type HBV was observed in HepG2, a human hepatoblastoma cell line. This finding of a profound replication advantage for mutant I97L in Huh7 and J3 cells but not in HepG2 cells may have important implications for the emergence of this mutant in chronic HBV carriers. We speculate here that the mutation confers a host factor-independent growth advantage for the survival of HBV variants in gradually dedifferentiating hepatocytes and thus helps prolong viral persistence.

AB - Mutations of human hepatitis B virus (HBV) occur frequently within the capsid (core) protein in natural infections. The most frequent mutation of the core protein in HBV from Southeast Asia occurs at amino acid 97, changing an isoleucine (I) to a leucine (L). In our systematic study of virus-host interactions, we have examined the replication efficiency of a site-directed mutant, I97L, and its parental wild-type HBV in several different hepatoma cell lines. Interestingly, we found that this capsid variant replicated in human Huh7 hepatoma cells approximately 4.8-fold better than its parental wild-type HBV. A similar phenomenon was observed in another hepatoma cell line, J3. In addition, the level of encapsidated RNA pregenome in mutant I97L was about 5.7-fold higher than that of the wild-type HBV in Huh7 cells. Unlike Huh7 cells, no significant difference in viral DNA replication between the same I97L mutant and its parental wild-type HBV was observed in HepG2, a human hepatoblastoma cell line. This finding of a profound replication advantage for mutant I97L in Huh7 and J3 cells but not in HepG2 cells may have important implications for the emergence of this mutant in chronic HBV carriers. We speculate here that the mutation confers a host factor-independent growth advantage for the survival of HBV variants in gradually dedifferentiating hepatocytes and thus helps prolong viral persistence.

UR - http://www.scopus.com/inward/record.url?scp=0036889379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036889379&partnerID=8YFLogxK

U2 - 10.1128/JVI.76.23.12069-12077.2002

DO - 10.1128/JVI.76.23.12069-12077.2002

M3 - Article

C2 - 12414948

AN - SCOPUS:0036889379

VL - 76

SP - 12069

EP - 12077

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 23

ER -